# SV Life Sciences' Biotech Investments: 23 Startups in Its Portfolio (2026) > The 23 Biotech startups SV Life Sciences has backed, by stage: $1.4B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/sv-life-sciences-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 9 - [Bicycle Therapeutics](https://millionrounds.com/company/bicycle-therapeutics) - [Lux Biosciences](https://millionrounds.com/company/lux-biosciences) - [*P* PanOptica](https://millionrounds.com/company/panoptica) - [*E* ESBATech](https://millionrounds.com/company/esbatech) - [*JB* Juvaris BioTherapeutics](https://millionrounds.com/company/juvaris-biotherapeutics) - [AlloCure](https://millionrounds.com/company/allocure) - [*O* OncoEthix](https://millionrounds.com/company/oncoethix) - [*KT* Karus Therapeutics](https://millionrounds.com/company/karus-therapeutics) - [CELLutions Biosystems](https://millionrounds.com/company/cellutions-biosystems) ## Stage not reported 6 - [AcuFocus](https://millionrounds.com/company/acufocus) - [EBR Systems](https://millionrounds.com/company/ebr-systems) - [*N* NeurogesX](https://millionrounds.com/company/neurogesx) - [Autifony Therapeutics](https://millionrounds.com/company/autifony-therapeutics) - [*CS* CHF Solutions](https://millionrounds.com/company/chf-solutions) - [*NT* NKT Therapeutics](https://millionrounds.com/company/nkt-therapeutics) ## Series C and later 5 - [Pulmocide](https://millionrounds.com/company/pulmocide) - [CSA Medical](https://millionrounds.com/company/csa-medical) - [Arsanis](https://millionrounds.com/company/arsanis) - [Adimab](https://millionrounds.com/company/adimab) - [*O* Oxagen](https://millionrounds.com/company/oxagen) ## Series A 3 - [*DT* Delenex Therapeutics](https://millionrounds.com/company/delenex-therapeutics) - [*CP* Convergence Pharmaceuticals](https://millionrounds.com/company/convergence-pharmaceuticals) - [Aligned TeleHealth](https://millionrounds.com/company/aligned-telehealth) ## Segment by segment ### Series B 9 startups · $484M raised - [**Bicycle Therapeutics**](https://millionrounds.com/company/bicycle-therapeutics) Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics. United Kingdom $110M - [**Lux Biosciences**](https://millionrounds.com/company/lux-biosciences) Lux Biosciences is a biotechnology company developing medicines for the treatment of ophthalmic diseases. United States $90M - [*P* **PanOptica**](https://millionrounds.com/company/panoptica) United States $86M - [*E* **ESBATech**](https://millionrounds.com/company/esbatech) ESBATech develops fully human antibody fragments for therapeutic applications, applying the single-chain antibody framework. Switzerland $63M - [*JB* **Juvaris BioTherapeutics**](https://millionrounds.com/company/juvaris-biotherapeutics) Juvaris BioTherapeutics develops adjuvanted vaccines and immunotherapeutics to treat cancer and infectious diseases. United States $55M - [**AlloCure**](https://millionrounds.com/company/allocure) AlloCure is a clinical-stage biotechnology company based in Burlington, Massachusetts, specializing in cell therapies for kidney d United States $47M - [*O* **OncoEthix**](https://millionrounds.com/company/oncoethix) Oncoethix is a clinical-stage biotechnology company developing cancer drugs. Switzerland $19M - [*KT* **Karus Therapeutics**](https://millionrounds.com/company/karus-therapeutics) Karus Therapeutics is a pharmaceutical research company that develops drugs to treat cancer and heart diseases. United Kingdom $7.6M ### Stage not reported 6 startups · $490M raised - [**AcuFocus**](https://millionrounds.com/company/acufocus) Acufocus is a medical device company that develops and markets KAMRA inlay for the treatment of near vision loss. United States $170M - [**EBR Systems**](https://millionrounds.com/company/ebr-systems) EBR Systems is a provider of wireless cardiac pacing system for millions of patients suffering from cardiac rhythm diseases. United States $161M - [*N* **NeurogesX**](https://millionrounds.com/company/neurogesx) NeurogesX develops and commercializes therapies for chronic peripheral neuropathic pain. United States $92M - [**Autifony Therapeutics**](https://millionrounds.com/company/autifony-therapeutics) Autifony Therapeutics is a clinical-stage biotechnology company founded in 2011 as a spinout from GSK. United Kingdom $32M - [*CS* **CHF Solutions**](https://millionrounds.com/company/chf-solutions) CHF Solutions designs and manufactures a device to remove excess fluid from patients suffering from fluid overload. United States $23M - [*NT* **NKT Therapeutics**](https://millionrounds.com/company/nkt-therapeutics) NKT Therapeutics is a privately held biotechnology company focused on developing therapeutics to treat cancer and other serious diseases. United States $12M ### Series C and later 5 startups · $358M raised - [**Pulmocide**](https://millionrounds.com/company/pulmocide) Pulmocide is a private biopharmaceutical company based in London, United Kingdom, founded in 2007. United Kingdom $110M - [**CSA Medical**](https://millionrounds.com/company/csa-medical) CSA Medical is a provider of innovative spray cryotherapy medical device solutions. United States $105M - [**Arsanis**](https://millionrounds.com/company/arsanis) Arsanis is a biopharmaceutical company developing infectious disease treatments based on bacterial protein and carbohydrate antigens. Austria $76M - [**Adimab**](https://millionrounds.com/company/adimab) Adimab is a leader in the discovery and engineering of fully human monoclonal and multispecific antibodies. United States $40M - [*O* **Oxagen**](https://millionrounds.com/company/oxagen) Oxagen develops small molecule drugs to treat inflammatory and respiratory diseases. United Kingdom $27M ### Series A 3 startups · $90M raised - [*DT* **Delenex Therapeutics**](https://millionrounds.com/company/delenex-therapeutics) Delenex Therapeutics is engaged in developing therapeutic antibody fragments for diseases with high unmet needs. Switzerland $41M - [*CP* **Convergence Pharmaceuticals**](https://millionrounds.com/company/convergence-pharmaceuticals) Convergence Pharmaceuticals is a biotechnology company focused on the development of novel analgesics for the treatment of chronic pain. United Kingdom $35M - [**Aligned TeleHealth**](https://millionrounds.com/company/aligned-telehealth) Aligned Telehealth is a provider of a SaaS-based platform used to offer telemedicine and healthcare management services. United States $13M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names SV Life Sciences as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Co-investors **Who invests with SV Life Sciences** 32 co-investors](https://millionrounds.com/portfolio-maps/sv-life-sciences-co-investors)[Sector portfolio **Guillermo Rauch's AI portfolio** 34 startups · $2.6B](https://millionrounds.com/portfolio-maps/guillermo-rauch-ai-portfolio)[Sector portfolio **Fusion Fund's AI portfolio** 31 startups · $1.1B](https://millionrounds.com/portfolio-maps/fusion-fund-2-ai-portfolio)[Sector portfolio **BioInnovation Institute's Biotech portfolio** 31 startups · $165M](https://millionrounds.com/portfolio-maps/bioinnovation-institute-biotech-portfolio)[Sector portfolio **Flourish Ventures' Fintech portfolio** 27 startups · $3.3B](https://millionrounds.com/portfolio-maps/flourish-ventures-2-fintech-portfolio)[Sector portfolio **Thomas Wolf's AI portfolio** 22 startups · $1.6B](https://millionrounds.com/portfolio-maps/thomas-wolf-ai-portfolio) ## Raising from investors like SV Life Sciences? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)